ScinoPharm Taiwan, Ltd. — Interim / Quarterly Report 2025

公開資訊觀測站

合併權益變動表

本資料由神隆公司提供

本期

| 民國114年前3季 | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 單位：新台幣仟元 | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 會計項目 | 普通股股本 | 股本合計 | 資本公積 | 法定盈餘公積 | 特別盈餘公積 | 未分配盈餘（或待彌補虧損） | 保留盈餘合計 | 國外營運機構財務報表換算之兌換差額 | 透過其他綜合損益按公允價值衡量之金融資產未實現評價(損)益 | 其他權益項目合計 | 庫藏股票 | 歸屬於母公司業主之權益總計 | 非控制權益 | 權益總額 |
| 期初餘額 | 7,907,392 | 7,907,392 | 1,294,689 | 783,817 | 185,856 | 480,227 | 1,449,900 | -28,638 | -97,539 | -126,177 | | 10,525,804 | | 10,525,804 |
| 提列法定盈餘公積 | 0 | 0 | 0 | 33,892 | 0 | -33,892 | 0 | 0 | 0 | 0 | | 0 | | 0 |
| 特別盈餘公積迴轉 | 0 | 0 | 0 | 0 | -59,679 | 59,679 | 0 | 0 | 0 | 0 | | 0 | | 0 |
| 普通股現金股利 | 0 | 0 | 0 | 0 | 0 | -276,759 | -276,759 | 0 | 0 | 0 | | -276,759 | | -276,759 |
| 本期淨利（淨損） | 0 | 0 | 0 | 0 | 0 | 95,670 | 95,670 | 0 | 0 | 0 | | 95,670 | | 95,670 |
| 本期其他綜合損益 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -77,748 | 725,979 | 648,231 | | 648,231 | | 648,231 |
| 本期綜合損益總額 | 0 | 0 | 0 | 0 | 0 | 95,670 | 95,670 | -77,748 | 725,979 | 648,231 | | 743,901 | | 743,901 |
| 權益增加(減少)總額 | 0 | 0 | 0 | 33,892 | -59,679 | -155,302 | -181,089 | -77,748 | 725,979 | 648,231 | | 467,142 | | 467,142 |
| 期末餘額 | 7,907,392 | 7,907,392 | 1,294,689 | 817,709 | 126,177 | 324,925 | 1,268,811 | -106,386 | 628,440 | 522,054 | | 10,992,946 | | 10,992,946 |

去年同期

| 民國113年前3季 | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 單位：新台幣仟元 | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 會計項目 | 普通股股本 | 股本合計 | 資本公積 | 法定盈餘公積 | 特別盈餘公積 | 未分配盈餘（或待彌補虧損） | 保留盈餘合計 | 國外營運機構財務報表換算之兌換差額 | 透過其他綜合損益按公允價值衡量之金融資產未實現評價(損)益 | 其他權益項目合計 | 庫藏股票 | 歸屬於母公司業主之權益總計 | 非控制權益 | 權益總額 |
| 期初餘額 | 7,907,392 | 7,907,392 | 1,294,689 | 755,145 | 98,176 | 494,884 | 1,348,205 | -88,156 | -97,700 | -185,856 | | 10,364,430 | | 10,364,430 |
| 提列法定盈餘公積 | 0 | 0 | 0 | 28,672 | 0 | -28,672 | 0 | 0 | 0 | 0 | | 0 | | 0 |
| 提列特別盈餘公積 | 0 | 0 | 0 | 0 | 87,680 | -87,680 | 0 | 0 | 0 | 0 | | 0 | | 0 |
| 普通股現金股利 | 0 | 0 | 0 | 0 | 0 | -237,222 | -237,222 | 0 | 0 | 0 | | -237,222 | | -237,222 |
| 本期淨利（淨損） | 0 | 0 | 0 | 0 | 0 | 242,008 | 242,008 | 0 | 0 | 0 | | 242,008 | | 242,008 |
| 本期其他綜合損益 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 66,099 | 4,591 | 70,690 | | 70,690 | | 70,690 |
| 本期綜合損益總額 | 0 | 0 | 0 | 0 | 0 | 242,008 | 242,008 | 66,099 | 4,591 | 70,690 | | 312,698 | | 312,698 |
| 權益增加(減少)總額 | 0 | 0 | 0 | 28,672 | 87,680 | -111,566 | 4,786 | 66,099 | 4,591 | 70,690 | | 75,476 | | 75,476 |
| 期末餘額 | 7,907,392 | 7,907,392 | 1,294,689 | 783,817 | 185,856 | 383,318 | 1,352,991 | -22,057 | -93,109 | -115,166 | | 10,439,906 | | 10,439,906 |